Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 08-Mar-2022 titled Alembic Pharmaceuticals announces its joint venture, Aleor Dermaceuticals Limited receives USFDA Final Approval for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/gram